Director sold ~$1.02M of Gilead Sciences
Scheduled in advanceLoading…
Director
Disclosures on record
10
Companies involved
1
Director sold ~$1.02M of Gilead Sciences
Scheduled in advanceDirector sold ~$685K of Gilead Sciences
Scheduled in advanceDirector sold ~$504K of Gilead Sciences
Scheduled in advanceDirector sold ~$462K of Gilead Sciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.